OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Parkinson's Disease Genetics and Pathophysiology
Gabriel E. Vázquez-Vélez, Huda Y. Zoghbi
Annual Review of Neuroscience (2021) Vol. 44, Iss. 1, pp. 87-108
Open Access | Times Cited: 155
Gabriel E. Vázquez-Vélez, Huda Y. Zoghbi
Annual Review of Neuroscience (2021) Vol. 44, Iss. 1, pp. 87-108
Open Access | Times Cited: 155
Showing 1-25 of 155 citing articles:
Neuropathology and molecular diagnosis of Synucleinopathies
Shunsuke Koga, Hiroaki Sekiya, Naveen Kondru, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 200
Shunsuke Koga, Hiroaki Sekiya, Naveen Kondru, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 200
iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders
Hideyuki Okano, Satoru Morimoto
Cell stem cell (2022) Vol. 29, Iss. 2, pp. 189-208
Open Access | Times Cited: 120
Hideyuki Okano, Satoru Morimoto
Cell stem cell (2022) Vol. 29, Iss. 2, pp. 189-208
Open Access | Times Cited: 120
LRRK2 and idiopathic Parkinson’s disease
Emily M. Rocha, Matthew T. Keeney, Roberto Di Maio, et al.
Trends in Neurosciences (2022) Vol. 45, Iss. 3, pp. 224-236
Open Access | Times Cited: 105
Emily M. Rocha, Matthew T. Keeney, Roberto Di Maio, et al.
Trends in Neurosciences (2022) Vol. 45, Iss. 3, pp. 224-236
Open Access | Times Cited: 105
Functionalized Nanomaterials Capable of Crossing the Blood–Brain Barrier
Shuai Zha, Haitao Liu, Hengde Li, et al.
ACS Nano (2024) Vol. 18, Iss. 3, pp. 1820-1845
Open Access | Times Cited: 77
Shuai Zha, Haitao Liu, Hengde Li, et al.
ACS Nano (2024) Vol. 18, Iss. 3, pp. 1820-1845
Open Access | Times Cited: 77
Advances in understanding the function of alpha-synuclein: implications for Parkinson’s disease
Paolo Calabresi, Giulia Di Lazzaro, Gioia Marino, et al.
Brain (2023) Vol. 146, Iss. 9, pp. 3587-3597
Open Access | Times Cited: 58
Paolo Calabresi, Giulia Di Lazzaro, Gioia Marino, et al.
Brain (2023) Vol. 146, Iss. 9, pp. 3587-3597
Open Access | Times Cited: 58
Danna Jennings, Sarah Huntwork‐Rodriguez, Maurits F. J. M. Vissers, et al.
Movement Disorders (2023) Vol. 38, Iss. 3, pp. 386-398
Open Access | Times Cited: 45
Polyamines in Parkinson's Disease: Balancing Between Neurotoxicity and Neuroprotection
Stephanie Vrijsen, Marine Houdou, Ana Cascalho, et al.
Annual Review of Biochemistry (2023) Vol. 92, Iss. 1, pp. 435-464
Open Access | Times Cited: 41
Stephanie Vrijsen, Marine Houdou, Ana Cascalho, et al.
Annual Review of Biochemistry (2023) Vol. 92, Iss. 1, pp. 435-464
Open Access | Times Cited: 41
Pathology in Parkinson’s Disease
Glenda M. Halliday, Yuhong Fu
Cambridge University Press eBooks (2025), pp. 194-201
Closed Access | Times Cited: 9
Glenda M. Halliday, Yuhong Fu
Cambridge University Press eBooks (2025), pp. 194-201
Closed Access | Times Cited: 9
Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease
Tiantian Li, Chuanqi Chu, Leilei Yu, et al.
Nutrients (2022) Vol. 14, Iss. 21, pp. 4678-4678
Open Access | Times Cited: 46
Tiantian Li, Chuanqi Chu, Leilei Yu, et al.
Nutrients (2022) Vol. 14, Iss. 21, pp. 4678-4678
Open Access | Times Cited: 46
Sensitive immunosensing of α-synuclein protein in human plasma samples using gold nanoparticles conjugated with graphene: an innovative immuno-platform towards early stage identification of Parkinson's disease using point of care (POC) analysis
Esmaeil Darvish Aminabad, Ahmad Mobed, Mohammad Hasanzadeh, et al.
RSC Advances (2022) Vol. 12, Iss. 7, pp. 4346-4357
Open Access | Times Cited: 45
Esmaeil Darvish Aminabad, Ahmad Mobed, Mohammad Hasanzadeh, et al.
RSC Advances (2022) Vol. 12, Iss. 7, pp. 4346-4357
Open Access | Times Cited: 45
Role of Nrf2 in Parkinson’s Disease: Toward New Perspectives
Xin-xing Yang, Rong Yang, Feng Zhang
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 45
Xin-xing Yang, Rong Yang, Feng Zhang
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 45
Mitochondrial Neurodegeneration
Massimo Zeviani, Carlo Viscomi
Cells (2022) Vol. 11, Iss. 4, pp. 637-637
Open Access | Times Cited: 43
Massimo Zeviani, Carlo Viscomi
Cells (2022) Vol. 11, Iss. 4, pp. 637-637
Open Access | Times Cited: 43
Irisin exhibits neuroprotection by preventing mitochondrial damage in Parkinson’s disease
Xi Zhang, Sutong Xu, Yong Hu, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 37
Xi Zhang, Sutong Xu, Yong Hu, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 37
Neuroinflammation in Parkinson’s Disease: From Gene to Clinic: A Systematic Review
Carlos Castillo-Rangel, Gonzalo Núñez Marín, Karla Aketzalli Hernández-Contreras, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5792-5792
Open Access | Times Cited: 26
Carlos Castillo-Rangel, Gonzalo Núñez Marín, Karla Aketzalli Hernández-Contreras, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5792-5792
Open Access | Times Cited: 26
Sphingolipids in neurodegenerative diseases
Xueyang Pan, Debdeep Dutta, Shenzhao Lu, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 24
Xueyang Pan, Debdeep Dutta, Shenzhao Lu, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 24
Parkinson’s disease updates: Addressing the pathophysiology, risk factors, genetics, diagnosis, along with the medical and surgical treatment
Priyadarshi Prajjwal, Herson S Flores Sanga, Kirtish Acharya, et al.
Annals of Medicine and Surgery (2023) Vol. 85, Iss. 10, pp. 4887-4902
Open Access | Times Cited: 24
Priyadarshi Prajjwal, Herson S Flores Sanga, Kirtish Acharya, et al.
Annals of Medicine and Surgery (2023) Vol. 85, Iss. 10, pp. 4887-4902
Open Access | Times Cited: 24
Role of Epigenetic Modulation in Neurodegenerative Diseases: Implications of Phytochemical Interventions
Mani Iyer Prasanth, Bhagavathi Sundaram Sivamaruthi, Clerance Su Yee Cheong, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 606-606
Open Access | Times Cited: 12
Mani Iyer Prasanth, Bhagavathi Sundaram Sivamaruthi, Clerance Su Yee Cheong, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 606-606
Open Access | Times Cited: 12
Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches
Zeba Firdaus, Xiaogang Li
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2320-2320
Open Access | Times Cited: 11
Zeba Firdaus, Xiaogang Li
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2320-2320
Open Access | Times Cited: 11
The ion channels of endomembranes
Meiqin Hu, Xinghua Feng, Qiang Liu, et al.
Physiological Reviews (2024) Vol. 104, Iss. 3, pp. 1335-1385
Open Access | Times Cited: 11
Meiqin Hu, Xinghua Feng, Qiang Liu, et al.
Physiological Reviews (2024) Vol. 104, Iss. 3, pp. 1335-1385
Open Access | Times Cited: 11
PRKN-linked familial Parkinson’s disease: cellular and molecular mechanisms of disease-linked variants
Lene Clausen, Justyna Okarmus, Vasileios Voutsinos, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 9
Lene Clausen, Justyna Okarmus, Vasileios Voutsinos, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 9
From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders
Elisa Duranti, Chiara Villa
Biology (2024) Vol. 13, Iss. 9, pp. 719-719
Open Access | Times Cited: 8
Elisa Duranti, Chiara Villa
Biology (2024) Vol. 13, Iss. 9, pp. 719-719
Open Access | Times Cited: 8
Emodin, a Potent Anthraquinone Mitigates MPTP-Induced Parkinsons’ Disease Pathology by Regulating Nrf2 and Its Downstream Targets: In Silico and In Vivo Approach
Sarwat Jahan, Muhammad Ikram, Sami Siraj, et al.
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Sarwat Jahan, Muhammad Ikram, Sami Siraj, et al.
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Development of an Innovative Three-Component Optical Resolution and a Flow Chemistry Process for (R)-Troloxamide Quinone (EPI-589)
Hirotsugu Usutani, Kiichi Kuroda, Kazuhiro SAWAMURA, et al.
Organic Process Research & Development (2025)
Closed Access | Times Cited: 1
Hirotsugu Usutani, Kiichi Kuroda, Kazuhiro SAWAMURA, et al.
Organic Process Research & Development (2025)
Closed Access | Times Cited: 1
Elucidating the Neuroprotective Role of PPARs in Parkinson’s Disease: A Neoteric and Prospective Target
Tapan Behl, Piyush Madaan, Aayush Sehgal, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10161-10161
Open Access | Times Cited: 46
Tapan Behl, Piyush Madaan, Aayush Sehgal, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10161-10161
Open Access | Times Cited: 46
A Critical Review of Zebrafish Models of Parkinson’s Disease
Jillian M. Doyle, Roger P. Croll
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
Jillian M. Doyle, Roger P. Croll
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
